Insulin Glargine Associated With Breast Cancer Risk in T2D
Women who received insulin glargine, compared with neutral protamine Hagedorn insulin, had a higher incidence of breast cancer.
Medically supervised, therapeutic fasting regimens can help reverse type 2 diabetes (T2D) and minimize the need for pharmacological interventions.
Among U.S. women, a normally high circulating prolactin concentration is associated with a reduced risk for type 2 diabetes.
Greater variation of fasting plasma glucose over time is associated with an increased risk of developing type 2 diabetes.